Titles
- Cleaner health care: hospital emissions mitigation1
- Community care hubs: a promising model for health and social care coordination1
- Competition in prescription drug markets, 2017-20221
- Complex, time-consuming, and frustrating: searching for in-network diabetes care with marketplace insurance1
- Compliance policy regarding blood and blood component donation suitability, donor eligibility and source plasma quarantine hold requirements: guidance for industry1
- Confirmed COVID-19 cases, metropolitan and nonmetropolitan counties1
- Connecticut Medicaid Fraud Control Unit: 2021 inspection1
- Connecticut implemented our prior audit recommendations and generally complied with federal and state requirements for reporting and monitoring critical incidents1
- Consent-to-share: California’s opportunity to modernize cross-sector data sharing1
- Considerations for the conduct of clinical trials of medical products during major disruptions due to disasters and public health emergencies: guidance for industry, investigators, and institutional review boards1
- Considerations for the use of real-world data and real-world evidence to support regulatory decision-making for drug and biological products: guidance for industry1
- Counties lean into CalAIM1
- Critical role of New York’s community health centers in advancing equity in Medicaid: investment in community health centers can help New York achieve its health equity goals1
- Cybersecurity in medical devices: quality system considerations and content of premarket submissions : guidance for industry and Food and Drug Administration staff1
- DSCSA standards for the interoperable exchange of information for tracing of certain human, finished, prescription drugs: guidance for industry1
- Defense health care: DOD assessment needed to ensure TRICARE behavioral health coverage goals are being met : report to congressional committees1
- Designing Medi-Cal consumer advisory committees: insights from a survey of Medi-Cal managed care plans1
- Development and licensure of vaccines to prevent COVID-19: guidance for industry1
- Development of monoclonal antibody products targeting SARS-CoV-2 for emergency use authorization: guidance for industry1
- Did disparities in access worsen during the pandemic?: comparing Californians with Medi-Cal and those with employer coverage1